Cargando…

Correction: An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies

Detalles Bibliográficos
Autores principales: Orlando, Eleonora, Medo, Matúš, Bensimon, Ariel, Quintin, Aurélie, Riedo, Rahel, Roth, Selina M., Riether, Carsten, Marti, Thomas M., Aebersold, Daniel M., Medová, Michaela, Aebersold, Ruedi, Zimmer, Yitzhak
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998563/
https://www.ncbi.nlm.nih.gov/pubmed/36894640
http://dx.doi.org/10.1007/s00018-023-04725-8
_version_ 1784903492208427008
author Orlando, Eleonora
Medo, Matúš
Bensimon, Ariel
Quintin, Aurélie
Riedo, Rahel
Roth, Selina M.
Riether, Carsten
Marti, Thomas M.
Aebersold, Daniel M.
Medová, Michaela
Aebersold, Ruedi
Zimmer, Yitzhak
author_facet Orlando, Eleonora
Medo, Matúš
Bensimon, Ariel
Quintin, Aurélie
Riedo, Rahel
Roth, Selina M.
Riether, Carsten
Marti, Thomas M.
Aebersold, Daniel M.
Medová, Michaela
Aebersold, Ruedi
Zimmer, Yitzhak
author_sort Orlando, Eleonora
collection PubMed
description
format Online
Article
Text
id pubmed-9998563
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-99985632023-03-11 Correction: An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies Orlando, Eleonora Medo, Matúš Bensimon, Ariel Quintin, Aurélie Riedo, Rahel Roth, Selina M. Riether, Carsten Marti, Thomas M. Aebersold, Daniel M. Medová, Michaela Aebersold, Ruedi Zimmer, Yitzhak Cell Mol Life Sci Correction Springer International Publishing 2023-03-10 2023 /pmc/articles/PMC9998563/ /pubmed/36894640 http://dx.doi.org/10.1007/s00018-023-04725-8 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Correction
Orlando, Eleonora
Medo, Matúš
Bensimon, Ariel
Quintin, Aurélie
Riedo, Rahel
Roth, Selina M.
Riether, Carsten
Marti, Thomas M.
Aebersold, Daniel M.
Medová, Michaela
Aebersold, Ruedi
Zimmer, Yitzhak
Correction: An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies
title Correction: An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies
title_full Correction: An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies
title_fullStr Correction: An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies
title_full_unstemmed Correction: An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies
title_short Correction: An oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies
title_sort correction: an oncogene addiction phosphorylation signature and its derived scores inform tumor responsiveness to targeted therapies
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998563/
https://www.ncbi.nlm.nih.gov/pubmed/36894640
http://dx.doi.org/10.1007/s00018-023-04725-8
work_keys_str_mv AT orlandoeleonora correctionanoncogeneaddictionphosphorylationsignatureanditsderivedscoresinformtumorresponsivenesstotargetedtherapies
AT medomatus correctionanoncogeneaddictionphosphorylationsignatureanditsderivedscoresinformtumorresponsivenesstotargetedtherapies
AT bensimonariel correctionanoncogeneaddictionphosphorylationsignatureanditsderivedscoresinformtumorresponsivenesstotargetedtherapies
AT quintinaurelie correctionanoncogeneaddictionphosphorylationsignatureanditsderivedscoresinformtumorresponsivenesstotargetedtherapies
AT riedorahel correctionanoncogeneaddictionphosphorylationsignatureanditsderivedscoresinformtumorresponsivenesstotargetedtherapies
AT rothselinam correctionanoncogeneaddictionphosphorylationsignatureanditsderivedscoresinformtumorresponsivenesstotargetedtherapies
AT riethercarsten correctionanoncogeneaddictionphosphorylationsignatureanditsderivedscoresinformtumorresponsivenesstotargetedtherapies
AT martithomasm correctionanoncogeneaddictionphosphorylationsignatureanditsderivedscoresinformtumorresponsivenesstotargetedtherapies
AT aebersolddanielm correctionanoncogeneaddictionphosphorylationsignatureanditsderivedscoresinformtumorresponsivenesstotargetedtherapies
AT medovamichaela correctionanoncogeneaddictionphosphorylationsignatureanditsderivedscoresinformtumorresponsivenesstotargetedtherapies
AT aebersoldruedi correctionanoncogeneaddictionphosphorylationsignatureanditsderivedscoresinformtumorresponsivenesstotargetedtherapies
AT zimmeryitzhak correctionanoncogeneaddictionphosphorylationsignatureanditsderivedscoresinformtumorresponsivenesstotargetedtherapies